Yupingfeng Powder (玉屏风散) was first recorded in Jiu Yuan Fang of the Southern Song Dynasty. It is composed of three herbs—Huangqi (Astragali Radix), Baizhu (Atractylodis Macrocephalae Rhizoma), and Fangfeng (Saposhnikoviae Radix)—and possesses the therapeutic effects of tonifying qi, consolidating the exterior, and arresting sweating. Existing reviews have primarily focused on its chemical constituents, pharmacological activities, or therapeutic progress in a single disease, whereas a systematic integration of the tripartite relationship among “clinical evidence-mechanism of action-material basis” remains insufficient. From a “multi-component, multi-target, multi-pathway” perspective, this article synthesizes the common regulatory networks of Yupingfeng Powder across different diseases, elucidates the scientific basis of its principle of “treating different diseases with the same method,” and proposes concrete research pathways across four dimensions: evidence-based validation, clinical therapeutic patterns, bioactive substances, and mechanisms of action. By constructing a four-in-one research framework, this review aims to advance the precise clinical application and in-depth development of Yupingfeng Powder.
ZHANG Junqi, JI Xuan, WANG Siyu, CHEN Biyi, OUYANG Qian, LI Ling, ZHONG Qing.
Advances in pharmacological mechanisms and clinical application of Yupingfeng Powder[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(13)
: 5308
-5317
.
DOI: 10.7501/j.issn.0253-2670.2026.13.031
邵长鑫, 林欢欢, 靳晓杰, 等. 黄芪的炮制历史沿革及现代研究进展 [J]. 中草药, 2023, 54(15): 5057-5074. 范信晖, 李科, 杨一丹, 等. 黄芪多糖中抗炎组分的结构及其活性的初步研究 [J]. 山西医科大学学报, 2021, 52(10): 1346-1356. Xu L, Xiao S N, Sun R R, et al. Assessment of the structural characterization and anti-inflammatory activities of various parts of Astragalus (root, stem, leaf, flower) from a polysaccharide perspective [J]. Int J Biol Macromol, 2026, 339(Pt 2): 149904. 石岩, 贾天颖, 李向日, 等. 黄芪中多种黄酮类成分的测定研究 [J]. 药物分析杂志, 2022, 42(7): 1120-1127. Tan J Y, Zhao J X, Zang Y, et al. New flavonoid glycosides from the stems and leaves of Astragalus membranaceus [J]. Fitoterapia, 2025, 180: 106321. 朱静坚, 伍春桃, 周玉磊, 等. 白术多糖指纹图谱和抗氧化活性的谱效关系分析 [J]. 理化检验: 化学分册, 2022, 58(6): 701-707. Wang R J, Zhou G S, Wang M Y, et al. The metabolism of polysaccharide from Atractylodes macrocephala koidz and its effect on intestinal microflora [J]. Evid Based Complementary Altern Med, 2014, 2014(1): 926381. Bo R N, Liu X P, Wang J, et al. Polysaccharide from Atractylodes macrocephala Koidz binding with zinc oxide nanoparticles: Characterization, immunological effect and mechanism [J]. Front Nutr, 2022, 9: 992502. 李梅, 蒋锦梅, 欧大明, 等. 白术多糖对类风湿性关节炎大鼠的抗炎作用及TLR4/NF-κB信号通路的影响 [J]. 安徽医科大学学报, 2022, 57(4): 552-557. Zhang Q W, Yang M J, Liao C Y, et al. Atractylodes macrocephala Koidz polysaccharide ameliorates DSS-induced colitis in mice by regulating the gut microbiota and tryptophan metabolism [J]. Br J Pharmacol, 2025, 182(7): 1508-1527. Xiang X L, Cao N, Chen F Y, et al. Polysaccharide of Atractylodes macrocephala koidz (PAMK) alleviates cyclophosphamide-induced immunosuppression in mice by upregulating CD28/IP3R/PLCγ-1/AP-1/NFAT signal pathway [J]. Front Pharmacol, 2020, 11: 529657. Li L, He Y H, Wang N, et al. Atractylone in the Atractylodes macrocephala rhizoma essential oil and its anti-inflammatory activity [J]. Molecules, 2023, 28(21): 7340. Jeong S Y, Kang D M, Kim H J, et al. Anti-Helicobacter pylori and anti-inflammatory sesquiterpenoids from the rhizoma of Atractylodes macrocephala [J]. Molecules, 2025, 30(15): 3142. Hao S S, Wang Q, Liu S, et al. Structural analysis of a soluble polysaccharide from the root of Atractylodis Macrocephala Rhizoma and its mechanism in alleviating ulcerative colitis in mice [J]. Int Immunopharmacol, 2026, 179: 116634. Wu Y X, Lu W W, Geng Y C, et al. Antioxidant, antimicrobial and anti-inflammatory activities of essential oil derived from the wild rhizome of Atractylodes macrocephala [J]. Chem Biodivers, 2020, 17(8): e2000268. Yue X W, Xu Y, Sun B, et al. Study on HPLC fingerprint of Saposhnikovia divaricata lipophilic components and anti-aging effects [J]. Sci Rep, 2024, 14: 25766. Yuan D Y, Wang Q Y, Yu Q, et al. Structural characterization of two glucans from Saposhnikovia divaricata and evaluation of their anti-neuroinflammatory activity [J]. Int J Biol Macromol, 2025, 322: 146781. Wang K H, Ke C Y, Wang X C, et al. Polysaccharide SP-3 derived from Saposhnikovia divaricata (Turcz.) Schischk. enhances immunity by regulating intestinal targets and gut microbiota [J]. Phytomedicine, 2026, 155: 158125. Bai Y X, Wei W L, Yao C L, et al. Advances in the chemical constituents, pharmacological properties and clinical applications of TCM formula Yupingfeng San [J]. Fitoterapia, 2023, 164: 105385. 黄福满, 宋亚军, 左童文, 等. 基于UPLC-Q-TOF-MS鉴定玉屏风散入血成分 [J]. 南京中医药大学学报, 2025, 41(5): 637-651. 王嵩, 邵路平, 郤庆, 等. 玉屏风散化学成分的研究 [J]. 中成药, 2017, 39(2): 342-346. 陈平, 林妹妹. 玉屏风散合煎液与单煎合并液HPLC图谱和其总黄酮与多糖含量的对比 [J]. 海峡药学, 2019, 31(8): 71-74. 刘宇欣, 张佳琪, 王思琦, 等. 玉屏风散化学成分及药理作用研究进展 [J]. 生物化工, 2024, 10(3): 179-183. 叶晓滨, 陈玉梅. 玉屏风散的现代药理研究及临床应用研究进展 [J]. 光明中医, 2021, 36(8): 1360-1365. 刘海叶, 葛美娜, 王杰鹏, 等. 基于UHPLC-QE-MS和网络药理学探讨玉屏风散治疗慢性阻塞性肺疾病作用机制 [J]. 国际中医中药杂志, 2024, 46(12): 1615-1621. Liu X M, Yu Y, Wu Y Q, et al. A systematic pharmacology-based in vivo study to reveal the effective mechanism of Yupingfeng in asthma treatment [J]. Phytomedicine, 2023, 114: 154783. 史俊祖, 王雪峰, 冯欣然. 玉屏风散化学成分、药理作用、临床应用研究进展及质量标志物预测分析 [J]. 辽宁中医药大学学报, 2024, 26(7): 48-54. Wu R M, Zhao N S, Li H Y, et al. Protective effects of Jiawei Yupingfeng polysaccharides on cyclophosphamide-induced intestinal injury in mice [J]. Int J Biol Macromol, 2025, 310: 143405. 尹学凤, 梁海东, 张华. 玉屏风散治疗慢性阻塞性肺疾病及对辅助性T细胞17/调节性T细胞平衡的影响 [J]. 西北药学杂志, 2022, 37(5): 135-138. 邓艳华, 陈璐佳, 刘宏飞, 等. 玉屏风散加味对气虚易感人群免疫功能的影响 [J]. 中国现代医生, 2021, 59(29): 138-141. 韩延南, 赵慧双, 刘芳, 等. 黄芪多糖通过TLR4/PI3K信号促进巨噬细胞吞噬铜绿假单胞菌 [J]. 中国免疫学杂志, 2025, 41(2): 381-386. 汲广全. 白术有效成分对巨噬细胞和树突状细胞免疫活性的研究 [D]. 广州: 华南理工大学, 2014. Lei X C, Liu C Z, Lin X J, et al. Effect of improved Yupingfeng Powder Prescription (玉屏风散加味) on interleukin-33/suppression of tumorigenicity 2 pathway in mice with ovalbumins-induced allergic rhinitis [J]. J Tradit Chin Med, 2025, 45(6): 1215-1227. 商玉立, 郭彩霞, 石红梅, 等. 黄芪多糖对哮喘小鼠气道炎症启动因子TSLP和DCs表达的影响 [J]. 中国抗生素杂志, 2021, 46(7): 711-716. 赵薇, 郝彦伟, 张怡, 等. 白术及其复方治疗炎症性肠病的研究进展 [J]. 中草药, 2024, 55(23): 8278-8289. Chen C L, Zhu M R, Li Y N, et al. Yupingfeng Formula exerts antiviral property by promoting IFN-I production and IgG1 antibody response [J]. J Med Virol, 2025, 97(12): e70723. 吴振波, 邵淑蓉, 陈虹宇. 黄芪多糖对呼吸道合胞病毒所致幼鼠肺部感染的抗病毒作用及其机制 [J]. 解放军医学杂志, 2022, 47(4): 346-352. Yao F, Yuan Q, Song X D, et al. Yupingfeng Granule improves Th2-biased immune state in microenvironment of hepatocellular carcinoma through TSLP-DC-OX40L pathway [J]. Evid Based Complementary Altern Med, 2020, 2020(1): 1263053. 张明慧, 王宗傲, 孙华, 等. 加味玉屏风散的抗肝癌效应及机制 [J]. 新乡医学院学报, 2025, 42(3): 169-177. 叶震中, 李世杰, 牛彩琴. 玉屏风散对肺癌细胞PD-L1表达及T细胞功能的影响 [J]. 中成药, 2024, 46(6): 1850-1856. 徐倩, 侯文跃, 高绍梅, 等. 玉屏风散调控RAGE/ MEK/ERK信号通路抑制HMGB1诱导下肝癌血管新生的作用和机制 [J/OL]. 中国实验方剂学杂志, (2025-09-26) [2026-01-16]. https://doi.org/10.13422/j.cnki.syfjx.20252027. Pei T L, Dai Y F, Tan X, et al. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS(2) technology [J]. J Ethnopharmacol, 2023, 306: 116134. 陈朝俊, 李志梁, 傅强, 等. 黄芪多糖应用于人外周血源性树突状细胞体外培养的实验研究 [J]. 南方医科大学学报, 2009, 29(6): 1192-1194. Li Q Y, Zhang C H, Xu G C, et al. Astragalus polysaccharide ameliorates CD8+ T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation‐induced colorectal cancer [J]. Biomed Pharmacother, 2024, 171: 116172. 孙舒玉, 何小鹃, 柴旺, 等. 黄芪多糖对黑色素瘤小鼠调节性T细胞的作用 [J]. 中国实验方剂学杂志, 2013, 19(12): 176-178. 陈瑾歆, 何军, 张娟娟, 等. 黄芪多糖对人肝癌细胞HepG2凋亡相关基因表达的影响 [J]. 中国老年学杂志, 2014, 34(1): 124-126. 龙家英, 李小芳, 王娴, 等. 白术抗肿瘤活性成分及其抗肿瘤机制研究进展 [J]. 中药与临床, 2021, 12(1): 65-71. 刘海叶, 骆姗, 贾智玲, 等. 玉屏风颗粒对慢性阻塞性肺疾病模型大鼠肺泡灌洗液代谢组学及肠道菌群的影响 [J]. 中医杂志, 2023, 64(20): 2116-2124. 李蓉蓉, 赵冰, 陈丹丹, 等. 中医药通过“肠-肺轴”治疗急性肺损伤的研究进展 [J]. 中草药, 2025, 56(9): 3305-3315. 郑劼, 包凯帆, 李伟, 等. 基于益气固表功效探讨玉屏风散抗过敏复发的作用及机制 [J]. 南京中医药大学学报, 2019, 35(5): 606-612. 张仲林. 从“肺开窍于鼻”理论探讨玉屏风散对变应性鼻炎的治疗 [J]. 江苏中医药, 2009, 41(10): 11-12. 王国仙. 玉屏风散联合苍耳子散治疗过敏性鼻炎临床研究 [J]. 新中医, 2024, 56(9): 16-21. 黄建军, 周浩, 黄攀, 等. 加味玉屏风汤联合常规治疗对肺脾气虚型过敏性鼻炎患者的临床疗效 [J]. 中成药, 2022, 44(2): 431-434. 罗齐平, 刘秋燕, 胡伟妮, 等. 玉屏风颗粒联合天灸疗法治疗肺脾气虚型小儿过敏性鼻炎的临床疗效 [J]. 世界中医药, 2021, 16(7): 1109-1112. 张根养, 苏涛, 李菁, 等. 玉屏风散调节变应性鼻炎辅助性T细胞免疫失衡的作用及肠道菌群介导机制 [J]. 药学进展, 2025, 49(8): 677-681. 写国斌, 赵菊芬, 魏源. 补肺健脾益气方合玉屏风散治疗肺脾气虚证支气管哮喘的疗效及对中医证候评分、免疫功能及炎性因子水平的影响 [J]. 四川中医, 2024, 42(11): 111-114. 汪严, 雷柯, 周永亮, 等. 消积豁痰汤加减联合玉屏风散对肺脾气虚型支气管哮喘患者疗效及免疫功能的影响 [J]. 中华中医药学刊, 2024, 42(3): 233-238. 凌海涛, 黄海, 莫健平. 玉屏风散联合穴位贴敷治疗小儿哮喘并发反复呼吸道感染的疗效及对炎症因子和免疫功能的影响 [J]. 世界中西医结合杂志, 2022, 17(7): 1463-1467. Mazur N I, Caballero M T, Nunes M C. Severe respiratory syncytial virus infection in children: Burden, management, and emerging therapies [J]. Lancet, 2024, 404(10458): 1143-1156. Reyes L F, Conway Morris A, Serrano-Mayorga C, et al. Community-acquired pneumonia [J]. Lancet, 2025, 406(10517): 2371-2388. 张翼, 肖晨, 许瑾慧. 玉屏风颗粒在儿童肺炎支原体肺炎中的临床应用观察 [J]. 当代医学, 2019, 25(28): 118-119. 卫娜, 王晓晓, 王映棋, 等. 玉屏风散加味方对慢性阻塞性肺疾病大鼠气道炎症微环境的影响 [J]. 现代中西医结合杂志, 2018, 27(5): 457-461. 洪彪. 玉屏风散合四物汤联合比阿培南治疗细菌感染性肺炎临床观察 [J]. 实用中医药杂志, 2022, 38(4): 557-559. 齐洁, 张清潭, 杨倩倩, 等. 玉屏风颗粒联合抗菌药物治疗老年社区获得性肺炎患者的临床疗效及对其淋巴细胞亚群的影响 [J]. 世界中西医结合杂志, 2023, 18(8): 1610-1615. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease [J]. Lancet, 2012, 379(9823): 1341-1351. 杨建波, 夏洪涛, 王衍华. 从肠黏膜屏障的角度探讨玉屏风散干预慢性阻塞性肺疾病的机制 [J]. 广州医科大学学报, 2025, 53(1): 15-19. 梁如生. 信必可结合玉屏风颗粒治疗慢性阻塞性肺疾病的临床疗效 [J]. 内蒙古中医药, 2019, 38(11): 60-61. 吕俊刚, 陈银魁, 胡斌清, 等. 玉屏风散加减和喘可治注射液治疗慢性阻塞性肺病109例临床观察 [J]. 山西医药杂志, 2014, 43(1): 62-64. 陈聪, 王琦, 苏泽琦, 等. 玉屏风颗粒调理气虚体质反复感冒患者临床观察 [J]. 中国实验方剂学杂志, 2018, 24(5): 182-187. 刘金莲, 聂江艳, 黄可, 等. 玉屏风散联合罗红霉素在支气管扩张稳定期患者中的应用价值 [J]. 中国药物经济学, 2019, 14(12): 104-106. 张美芳, 张淑美, 宋海红, 等. 玉屏风散联合舒利迭气雾剂预防毛细支气管炎复发100例 [J]. 中国中医急症, 2012, 21(10): 1655. 张文雷, 王耀光. 王耀光运用黄芪系列方治疗肾脏病临床经验 [J]. 天津中医药, 2021, 38(4): 442-446. Li Y J, Bai Y W, Du Y, et al. Yu Ping Feng Powder for chronic glomerulonephritis treatment: A Meta-analysis and network pharmacology study [J]. J Chin Pharm Sci, 2023, 32(12): 1006-1026. 杨阳, 陈芳, 刘畅, 等. 五苓散合玉屏风散加减治疗儿童过敏性紫癜肾炎肾病型随机对照研究 [J]. 中国中西医结合杂志, 2023, 43(4): 435-440. 江锋. 玉屏风散联合西药治疗慢性荨麻疹临床观察 [J]. 中国中医药现代远程教育, 2024, 22(8): 146-148. 刘春保, 陆江涛, 孔珍珍, 等. 基于Th17/Treg平衡轴观察桂枝汤合玉屏风散加减治疗慢性自发性荨麻疹的临床疗效 [J]. 中药新药与临床药理, 2024, 35(11): 1781-1787. 关吉利, 陆江涛, 孔珍珍, 等. 加味玉屏风散联合枸地氯雷他定治疗老年慢性荨麻疹的疗效及对患者凝血指标的影响 [J]. 中国老年学杂志, 2022, 42(22): 5552-5555. 王宁, 吴春雁, 颜志芳. 加味玉屏风颗粒联合益生菌治疗慢性自发性荨麻疹的临床疗效和安全性 [J]. 中国药师, 2023(12): 442-448. 程传刚, 刘燕. 加味玉屏风散对晚期肝癌患者肝癌标志物水平及细胞免疫指标的影响 [J]. 江西中医药, 2025, 56(12): 55-58. 王宗傲, 张明慧, 孙华, 等. 加味玉屏风散治疗气虚毒瘀型晚期肝癌的临床研究 [J]. 南京中医药大学学报, 2024, 40(4): 413-418. 于礼建, 戎煜明, 黄圆圆, 等. 张蓓教授治疗肺癌用药经验 [J]. 亚太传统医药, 2021, 17(7): 116-119. 赵亚东, 王福庆, 高亚军. 加味玉屏风散对中晚期肺癌化疗后肺脾气虚型患者生活质量及免疫功能的影响 [J]. 现代中西医结合杂志, 2024, 33(1): 83-86.
PDF下载
全屏
24
8
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
